Next Article in Journal
Impacts of MicroRNA-483 on Human Diseases
Next Article in Special Issue
Crosstalk between Long Non-Coding RNA and Spliceosomal microRNA as a Novel Biomarker for Cancer
Previous Article in Journal / Special Issue
Small Nucleolar (Sno)RNA: Therapy Lays in Translation
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

LncRNA Functional Screening in Organismal Development

State Key Laboratory of Reproductive Medicine and Offspring Health, Nanjing Medical University, Nanjing 211166, China
*
Authors to whom correspondence should be addressed.
These authors contributed equally to this work.
Non-Coding RNA 2023, 9(4), 36; https://doi.org/10.3390/ncrna9040036
Submission received: 10 May 2023 / Revised: 23 June 2023 / Accepted: 26 June 2023 / Published: 28 June 2023
(This article belongs to the Special Issue Recent Advances in Chemical Biology to Study and Target ncRNAs)

Abstract

:
Controversy continues over the functional prevalence of long non-coding RNAs (lncRNAs) despite their being widely investigated in all kinds of cells and organisms. In animals, lncRNAs have aroused general interest from exponentially increasing transcriptomic repertoires reporting their highly tissue-specific and developmentally dynamic expression, and more importantly, from growing experimental evidence supporting their functionality in facilitating organogenesis and individual fitness. In mammalian testes, while a great multitude of lncRNA species are identified, only a minority of them have been shown to be useful, and even fewer have been demonstrated as true requirements for male fertility using knockout models to date. This noticeable gap is attributed to the virtual existence of a large number of junk lncRNAs, the lack of an ideal germline culture system, difficulty in loss-of-function interrogation, and limited screening strategies. Facing these challenges, in this review, we discuss lncRNA functionality in organismal development and especially in mouse testis, with a focus on lncRNAs with functional screening.

1. Introduction

Mammalian cells house tens of thousands of long noncoding RNAs (lncRNAs) [1]. By far, dozens of them are well documented as being functional [2,3]. Needless to say, this only represents a minute fraction of the total. Relative to those shown in cell lines, a smaller number of lncRNAs are demonstrated to perform a function required for proper organismal development [4,5]. Even less recognized is the functionality of the mammalian testicular lncRNAs, few of which are fully validated as having a true role in either spermatogenesis or male fertility in knockout mouse models [6], although the testis expresses numerous species of lncRNAs [7,8]. Until now, how large a fraction of lncRNAs represent biological significance remains a central puzzle, fueling a long-lasting debate [9,10,11,12,13,14]. Some researchers argue that even though many useful lncRNAs do exist, the majority are not meaningful, regardless of whether or not they are transcribed excessively [15,16]. This opinion comes from several aspects. From a genomic perspective, recent global transcriptome profiling across eukaryotic organisms demonstrates that at least 85% of the genome is transcribed, which is far more than expected [17]. However, only 10% of the Pol II activities in yeast initiate from conventional promoters and the remaining events are noise [15]. Other evidence comes from several studies using mouse knockout models with the deletion of large DNA fragments that transcribe hundreds of transcripts. Nevertheless, these models reveal no apparent phenotype [18] and many functionless lncRNAs in animal models have been reported [19,20,21]. In contrast, other researchers claim that the functional discovery of lncRNA genes, which are difficult relative to protein-coding genes, is still in its infancy [22]. Still, a repository of functional lncRNAs has been compiled and appreciated [3]. It is thus conceivable that buried in the mass of junk transcripts could be a large proportion of functional lncRNAs that are, nevertheless, emerging like the tip of an iceberg [9,23].
Although much attention has been focused on the discovery of bona fide functional lncRNAs at the organismal level, this field is moving slowly. The human genome harbors a magnitude of lncRNA gene loci, ranging from 59,000 up to 102,000, based on different databases [24,25,26]. About 80% of the human genome is actively transcribed through the body’s development to adulthood [27]. While nearly 2000 lncRNAs have a putative functional association, most of them are described solely in cell lines and have yet to be studied in tissues [3]. To date, only a few lncRNAs have been functionally identified using animal models [2]. A thorough dissection of the functionality of a given lncRNA in organ development calls for effective and multipronged strategies. In this article, we review recent advances in screening and probing functional lncRNAs in organismal development, with an emphasis on testicular lncRNAs.

2. LncRNA Functionality: Prediction Rationale

With the advent of next-generation RNA sequencing technologies, the expressions of lncRNAs have been subjected to high-throughput analyses in various types of cells or tissues [4,28]. Compared with protein-coding genes, lncRNAs are expressed at lower levels while more specifically, i.e., in a cell type-, tissue-, developmental stage-, or disease state-specific manner [29,30,31]. Most lncRNAs are more tightly regulated than protein-coding genes, contending for a central role of lncRNAs in the cell state determination [32,33]. Thus, discerning functional subsets from a magnitude lncRNA pool is a priority [34] but has become a major hurdle in the field. Screening efforts based on common criteria such as physical gene locus proximity, lncRNA-gene co-expression, and sequence conservation, together with individualized paradigms, have pointed to the role of lncRNA in mammalian organ development [8]. For example, in cis co-expression of lncRNA and nearby genes has been widely applied to predicting functional lncRNAs. However, such a prediction strategy has been challenged in that co-activation of neighboring genes is driven by multiple lncRNA-associated mechanisms, such as enhancer-like DNA locus, splice sites, or transcriptional activity, but not exclusively by the lncRNA transcript itself [35]. Moreover, there are always contrasting variations across different species or organs, leading to generally limited efficacy in picking out bona fide functional lncRNAs [34]. Therefore, reconsidering traditional strategies to achieve a higher probability of mining out functional lncRNAs is now on the horizon.

3. Functional Screening: Cell Lines vs. Animal Models

Benefiting from fast and easy manipulation as well as low cost, cultured cell lines serve as an important platform to decrypt the functionality of individual lncRNAs. Moreover, these advantages make cell lines an ideal system for high-throughput lncRNA functional screening. Indeed, RNAi-, CRISPR/Cas9-, CRISPR/dCas9-, or CRISPR/Cas13-based screening strategies have successfully identified a dozen lncRNAs functioning in cell differentiation, growth, or response to stimuli [36,37,38,39]. While these seminal studies clearly demonstrate the role of lncRNAs, only a small subset of lncRNAs functioning in cell lines could be recapitulated in mouse models. A representative example is Malat1, which regulates growth-control genes at both the transcriptional and post-transcriptional levels [40]. Nevertheless, in vivo knockout mice show normal development and fertility [41]. Another example is Evx1as, which promotes EVX transcription in cis and regulates mesendodermal differentiation in pluripotent cell lines [42]. Nevertheless, Evx1as-ablated mice are viable with no obvious abnormality [19]. Similar contradictory outcomes from cell lines versus animal models are de facto often obtained and discussed in more cases [2].
Regardless of the long manufacturing period and heavy expenditure, the convincing level of lncRNA functional studies requires appropriate LOF manipulation on animals. Indeed, CRISPR/Cas9-based screening using different animal models, including C. elegans, Drosophila, zebrafish, and mouse, has been fruitful, but displays variable results since its emergence. Goudarzi et al. selectively tested 25 candidate lncRNAs based on their conservation, expression trait, and proximity to developmental regulators, showing that lncRNAs have no overt roles in zebrafish [20]. Schor et al. deleted 3 out of 362 lncRNAs with specific spatiotemporal expression in Drosophila embryogenesis but yielded no obvious phenotypes in normal conditions or under stress factors [43]. In addition, the genetic ablation of six cardiac-specific mouse lncRNAs with distinct transcriptional and epigenetic patterns resulted in no defects [44]. Despite these negative screening results in terms of the biological significance of tested lncRNAs, some other screens were more or less successful. Sauvageau et al. filtered out 18 lncRNAs with epigenetic modification for active transcription and conservation between mouse and human, of which three mutant strains displayed lethality and two exhibited growth defects [45]. A large-scale evaluation of 155 C. elegans knockouts of intergenic lncRNAs (lincRNAs) revealed phenotypes of 23 knockouts [46]. Another functional examination of 10 C. elegans knockouts revealed six lncRNAs required for normal development and fertility [47]. A canvass of lncRNA functional screens at the animal level is presented here in Table 1. As such, two groups of screens led to opinions that could be paradoxical regarding the prevalence of lncRNA functionality in animals, which has rather confused researchers. The in vivo lncRNA functional screens are far less fruitful than the progress in understanding their modes of mechanistic action. This gap is attributed to several explanations [2], including non-specific or off-target effects [48], transcript-independent mechanisms [35,49], functional redundancy [50], non-conserved function among species [51], and a stress- or disease-responsive role [4], as well as a missed phenotype [52,53].
Based on the research discussed above, cell lines and animal models have both advantages and disadvantages in functional screening. A combinational screen using both may allow for attaining a complementarity between large-scale screening ex vivo and the discovery of truly functional lncRNAs in vivo. Perhaps feasibly, for preliminary filtering, high-throughput RNAi or knockout approach can be exploited in primarily derived cell lines and, meanwhile, knockout models can be designed for endogenous validation of potential functional subsets. Indeed, several recent screens applied this dual-means strategy and therefore discovered dozens of lncRNAs in various cell lines and also in their corresponding organs [54,55,56] (Table 1).
Table 1. Strategy and efficiency of current knockout-based functional screening of lncRNAs in animals.
Table 1. Strategy and efficiency of current knockout-based functional screening of lncRNAs in animals.
OrganismQueried Object of Organismal DevelopmentScreening CriteriaKnockout Screening ToolsKnockout Screening ResultsReference
Expression Specificity or DynamicityExpression AbundanceConservationActive Epigenetic StatusPhysical Proximity with RegulatorsCo-expression with RegulatorsOther Screening Criteria
C. elegansBody development and fertility CRISPR-Cas96/10[47]
C. elegansBody development and fertility CRISPR-Cas923/155[46]
DrosophilaEmbryogenesis CRISPR-Cas90/3[43]
DrosophilaSpermatogenesis CRISPR-Cas933/105[57]
ZebrafishEmbryogenesis, viability, fertility CRISPR-Cas90/25[20]
MouseIntestine development Pre-screen in cell linesCRISPR-Cas91/1[56]
MouseNeuroregeneration Pre-screen in cell linesCRISPR-Cas91/1[54]
MouseCardiomyocyte development Pre-screen in cell linesHomologous recombination 1/1[55]
MouseBody development Homologous recombination 5/18[45]
MouseHeart development CRISPR-Cas90/6[44]
MouseBody development Pre-screen in cell linesCRISPR-Cas91/12[19]

4. Testicular LncRNAs: Functionality

Over the past decade, an intense issue has raised the question of how functional lncRNAs originate from pervasive transcription [23,58]. A meaningful explanation is that functional lncRNAs occasionally evolve from a vast pool of non-functional transcripts via a mechanism similar to constructive neutral evolution [23]. In other words, only those organisms that produce a large quantity of junk RNAs possess many functional lncRNAs. Fitting this opinion, lncRNAs are highly expressed in nervous systems, where intensive research has revealed several subsets with physiological roles in neurogenesis, a field moving far beyond others [59].
Actually, the adult testis displays the highest transcriptome complexity among the tissues [8,60,61]. On one hand, during meiosis, chromatin relaxation activates a transcriptional burst of genic and intergenic RNAs, particularly lncRNAs, endo-siRNAs and pachytene piRNAs, along with transpositional shuffling to promote genomic and transcriptomic variability [62]. On the other hand, endo-siRNAs and pachytene piRNAs generated from antisense transcripts, usually from transposon sequences, guide the degradation of mRNAs and lncRNAs that could be useless or even deleterious, referred to as a molecular mechanism for genome-wide quality control [62,63]. Combined, the extensive transcription and targeted degradation of lncRNAs accelerate lncRNA evolution under robust screening through natural selection filters in mammalian spermatogenesis, giving rise to the thriving birth of young lncRNAs and preservation of optimized ones thereof [7,62]. All these clues highlight the significance of lncRNAs in spermatogenesis and hint at the existence of not a few functional ones. Although massive novel spermatogenic lncRNAs have been identified, most of them are biologically uncharacterized.
Several studies show the role of lncRNAs in male germ cells, which was summarized in recent reviews [6,64,65,66]. Here, we introduce functional lncRNAs with a focus on how to screen them in testis. So far, we still know little about lncRNA function in spermatogenesis, especially in mammals. There are only four lncRNA knockout models displaying obvious phenotypes (Figure 1). The first case is Tsx (testis-specific X-linked), whose knockout males were fertile with normal spermatogenesis [67]. Nonetheless, Tsx knockout resulted in a mild increase in the apoptosis of pachytene spermatocytes, an additional maternal-specific effect on litter size, and dysfunction of multiple other cell types. The second case is Tesh1, whose knockout males were subfertile with teratospermia and offspring with female-biased sex ratios [68]. The third case is Tug1 (taurine-up-regulated gene 1), whose knockout males were sterile with decreased sperm counts and malformed sperm morphologies [69]. However, Tug1 may not act merely as a lncRNA transcript because there are two additional attributive layers: as a cis-DNA regulator and as a protein-coding gene [69]. We still know little about whether these mechanisms alone or jointly contribute to its function in spermatogenesis [22]. The last case is Gm9999, which encodes two small peptides named Kastor and Polluks, respectively. Deletion of both peptides caused male subfertility with teratospermia and deletion of one peptide partially reproduced the phenotype, suggesting that Gm9999 regulates spermatogenesis on the dependence of peptide generation [70]. These four rarely reported knockout mouse models that exhibit either mild or non-lncRNA transcript-exclusive effects on male fertility implicate a general difficulty in decoding the functional tacitness and complexity of testicular lncRNAs.

5. Testicular LncRNAs: Functional Screening

In one systematic study consisting of the functional screening of testicular lncRNAs, Wen et al. identified 128 testis-specific Drosophila lncRNAs and knocked out 105 of them [57]. Among these knockouts, 33 (31%) showed visual developmental defects in late male germ cells and a partial or complete loss of male fertility. This result supports the pervasive involvement of functional lncRNAs, at least in late spermatogenesis, and for the first time, supports a general relevance of lncRNAs to testis function. This study employed RNAi and rescue experiments to determine in cis or in trans regulation of gene expression and also to separate RNA-dependent lncRNA function from DNA-dependent effect. From an evolutionary viewpoint, a constant proportion (around 30% of the entire pool) of functional lncRNA sequences are likely accumulating all along, nearly equal in percentage to this study [57]. In another functional screen in mouse testis, Li et al. conducted global lncRNA expression profiling in six types of spermatogenic cells and subsequent filtering was based on protein-coding gene co-expression analysis and physical proximity with spermatogenic regulators [71]. They finally selected six lncRNA candidates and employed an shRNA-knockdown system in the testis to interrogate their in vivo function. As a result, two out of six candidate-depleted testes exhibited overt developmental defects in spermatogenesis. Fascinatingly, these screens in the testis of different species seem more efficient than in other tissues, supporting the aforementioned assumption that testicular transcriptome may comprise a relatively larger pool of functional lncRNAs.

6. Opportunities and Challenges

Due to our limited knowledge of lncRNA function in spermatogenesis, distinguished questions remain open. One notable question is whether lncRNAs are of significant importance in meiosis. The pervasively accessible chromatin observed during the meiotic progress includes intergenic regions [61], known as the major loci of lncRNA genes. As most stages of meiosis exhibit open chromatin states, tremendous lncRNAs are transcribed in spermatocytes, confirmed via single-cell RNA-seq analysis [72]. Moreover, several lncRNAs escape meiotic sex chromosome inactivation (MSCI) in pachytene spermatocytes and play potential roles in meiosis [73]. Although several mammalian spermatocyte-expressed lncRNAs have been functionally characterized, all of these studies rely on cell-based assays or have not produced an apparent phenotype in knockout mouse models [6,74,75,76]. More functional insights about meiotic lncRNAs are derived from yeast systems. One early study suggests a regulatory role of anti-sense lncRNA during the mitosis-to-meiosis transition [77]. Later studies identified a set of functional lncRNAs that regulate meiotic-specific chromosomal events at the transcriptional or post-transcriptional level [78]. Considering the potentially larger pool of lncRNAs and their complicated regulation in higher eukaryote systems, we reason that a considerable portion of lncRNAs perform a function in meiosis, which has yet to be explored.
Another obstacle that hampers our understanding of lncRNA functionality is our poor knowledge of the subcellular compartmentalization of lncRNAs in germ cells. It is well established that the localization of lncRNA is well suggestive of its cellular function [79,80]. Given its close relationship to molecular roles, subcellular localization would hopefully lift the cloud of mystery off lncRNA functionality. To date, lncRNAs have been detected in most of the general cellular organelles and granules [80]. However, our understanding of the subcellular localization of spermatogenic lncRNAs remains scarce. It is interesting to address how many lncRNAs are physically associated with germ-cell-specialized organelles and membraneless granules, such as the synaptonemal complex, the chromatoid body (CB), or acrosome. As mentioned previously, lncRNAs, along with RNA-binding proteins (RBPs) and other non-coding RNAs, constitute ribonucleoproteins (RNPs) and regulate synaptonemal complex formation directly [81]. Moreover, previous analysis of the CB component identified numerous lncRNA transcripts, suggesting their significance in CB assembly or function [82]. All of these findings hint that lncRNAs constitute spermatogenic RNPs and play a role in spermatogenesis. Furthermore, to what extent are lncRNAs functionally involved in the formation or function of these organelles in the process of piRNA biogenesis, meiosis, or sperm–egg recognition? A general method uses high-resolution imaging techniques, such as fluorescence in situ hybridization (FISH) and CRISPR/Cas13, to define lncRNA single-molecule localization [83,84,85]. An alternative method uses high-specificity biochemical methods, such as subcellular organelle purification coupled with RNA-seq or APEX-RIP, to detect high-throughput lncRNA-organelle associations [86,87]. Such methodological application to spermatogenic cells will speed our progress in decoding lncRNA function in the context of lncRNA-organelle association in spermatogenesis. In addition, technical advances in probing protein-bound lncRNAs hold equivalent promise at more refined layers of molecular interaction.
Most present screens focus on lincRNAs transcribed from intergenic regions, whereas other types of lncRNAs derived from introns (intronic lncRNAs) and gene regulatory regions (such as promoter lncRNAs and enhancer lncRNAs, elncRNAs/eRNAs) are rarely considered for screening, mainly because these lncRNAs are unstable and thus presumed to lack a function [88,89]. However, recent findings have challenged these stereotypes, showing that at least some of them play important biological roles [89,90]. Special attention should be paid to the new understanding of enhancers and enhancer-derived lncRNAs (elncRNAs). Enhancers control precise spatiotemporal gene expression and are thus the key regulators for cell specification and organ development [91,92]. Enhancers bind transcription factors that are presumed to interact with target promoters but more likely are responsible for the transcription of elncRNAs [93]. Enhancers are widely transcribed and many, if not most, lncRNAs are derived from enhancers [93,94,95], including some lncRNAs previously defined as a locus in intergenic regions [96]. elncRNAs can modulate DNA/histone modification as well as chromatin organization by binding to other RBPs or transcriptional factors [93,94,97]. Several elncRNAs are essential for organ development, such as Evf2 [98], Peril [99], Firre [100], and Maenli [101], suggesting the physiological role of elncRNAs in vivo. Hence, elncRNAs are likely to be strong potential candidates in functional screening. Following elncRNA pre-screening, we must design thoughtful LOF strategies [101] and rigorously interpret phenotypes of animal models to distinguish the pure role of elncRNA as a complicated transcript influenced by its enhancer DNA locus or by its transcriptional activity [22].
In the testis, the expression of thousands of germline-specific genes gives rise to the most diverse and complex testicular transcriptome among all organs [61,102]. Discontinuous transcriptional states were coupled with unique chromatin remodeling across spermatogenesis [103]. To modulate these accurately monitored processes, germline-specific enhancers and associated regulation likely generally exist, despite the lncRNA expressed in testis are unlikely to be mainly derived from enhancers [71]. Indeed, the mitosis-to-meiosis transcriptome transition is driven by a switching from mitotic to meiotic super enhancers (SEs) [104]. Moreover, distinct regulation of meiotic Ses was observed on autosomes versus the sex chromosomes [104]. We believe that the testis harbors more functional elncRNAs than other tissues, which are only beginning to be unveiled with our understanding of spermatogenic enhancers.

7. Loss-of-Function Tools

Loss-of-function (LOF) methods are widely used to functionally interrogate or validate lncRNAs in cells and animals, including CRISPR-Cas gene-editing systems, RNA interference (RNAi), and antisense oligonucleotide (ASO). Several reviews compared their advantages and disadvantages and discussed their applicability based on different modes of action [22,34,105,106,107]. These LOF tools are being effectively utilized in the area of spermatogenesis. For example, CRISPR-Cas9-based knockout tools enabled a large-scale functional screen in Drosophila testis [57]. However, these tools cannot preclude that the DNA locus of a lncRNA plays a role, even if not dominantly, in producing a phenotype [108]. In the screening of mouse testicular lncRNAs, adeno-associated viral (AAV)-delivered shRNA-mediated knockdown was successfully applied in testis [71]. However, substantial knockdown efficiency of RNAi is not guaranteed in the nucleus [109,110], where lncRNAs are transcribed and may have the propensity to reside [88,111]. Superior to RNAi with respect to this point, ASO and CRISPR-Cas13 systems can be more efficient in targeting nuclear lncRNAs [110,112].
Furthermore, shRNA-based knockdown in testis showed the bias of targeting Sertoli cells rather than germ cells [113,114]. In addition, a virus-based delivery system needs intricate preparation of virus packaging, posing biohazard risks and artificial effects. Although siRNA avoids these shRNA-relevant caveats, its instability and transiency limit the use of siRNA for maintaining a long-term knockdown effect. In contrast, ASO can last several weeks and is widely used in disease treatment in mammals and humans [115,116]. Moreover, ASO can directly act on nascent transcripts to prevent transcription, whereas siRNA-mediated knockdown performs solely at the post-transcriptional level [117]. Thus, ASO can have a LOF effect on a lncRNA inclusive of its nascent or mature form. Our group recently established the technique of microinjecting ASO into living mouse testis to negatively modulate the levels of a target lncRNA [118]. Using FISH and a battery of other assays, we showed that ASO performed better than siRNAs in Tsx knockdown in recapitulating the phenotype of Tsx knockout. This study lays the groundwork for the fast interrogation of lncRNA functionality in testis. It is worth noting that ASO has a broad scope of applications not only in biological research but also in clinical trials [107], thanks to its merits, including easy nuclear accessibility, lack of need for delivery reagents, and low biological toxicity [119,120], which would be beneficial for reproductive health and therapy.
In general, RNAi serves as the most convenient approach for large-scale functional screening of lncRNAs both in vivo and in vitro [36,121]. Comparatively, ASO is more efficient, albeit more expensive, for nucleus-enriched lncRNA knockdown. Although the CRISPR-Cas9 gene editing completely ablates lncRNA transcripts and still represents the key benchmark to proclaim a functional lncRNA, we must carefully formulate the knockout designs and cautiously interpret the results when this lncRNA overlaps with other genes or regulatory elements.

8. Future Strategies for Screening

Overall, the present screening strategies are somewhat homogeneous and require more attempts to identify lncRNAs of biological meaning in development such as in spermatogenesis. It is widely accepted that surveyed lncRNAs can be predicted to be functional as a result of their multiple common features, which usually include expression abundance, sequence conservation, gene locus, and transcriptional states (Figure 2 and Table 1). The rank of lncRNA expression level, as one plausibly reasonable criterion, might always be overestimated in prioritizing putative functional candidates [17,122]. Another representative criterion worth discussion is the linkage of functionality and sequence conservation. However, even a conserved lncRNA may differ in the route of biogenesis or subcellular transport, leading to a distinct role in different species or organisms [51].
To select the best probable pool of candidate lncRNAs for functional interrogation using LOF approaches, we need to carefully gain as many properties as possible by tracing them from being transcribed at genomic loci to being post-transcriptional processed, and adopt rational and insightful strategies. Additional function-predictable features that might have been underestimated include, but are not limited to, subcellular localization, sequence/motif, secondary/tertiary structure, and interaction with protein regulator, RNA regulator, or DNA element (Figure 2). Although some of these topics are just beginning to be underpinned, inspired by some cutting-edge explorations [123,124,125,126], we hold promise to advance this field under joint efforts of scientific communities. For example, a recent study decoded that lncRNAs sharing similar small sequence (K-mers) contents have related functions although they lack a linear homology [127]. This work implies that short lncRNA elements are potential indicators for lncRNA functionality and can be used for high-throughput screening. For another delicate example, Khalil et al. profiled PRC2-associated lncRNAs, and the knockdown of certain subsets led to gene expression changes, with the up-regulated genes being globally silenced by PRC2 [128]. It is worth noting that PRC2-associated lncRNAs, such as HOTAIR and TUG1, were further demonstrated to function in vivo [69,129], suggesting that those lncRNAs that associate with central regulators of development can be investigated further. Moreover, other assays specialized in the detection of lncRNA-protein, lncRNA-DNA, or lncRNA-RNA interaction; secondary/tertiary structure; and subcellular localization will provide important clues for screening [130,131,132] (Figure 2).
In addition, many criteria for lncRNA characteristics are interconnected. The functional elements of lncRNA always determine its subcellular localization or protein chaperone [133,134]. LncRNA functional sequences/motifs are preconditioned to form secondary/tertiary structures in vivo, and both can be recognized by protein regulators to coordinate biological roles [5]. With our growing mechanistic understanding of lncRNAs, we will be able to more integratively and creatively screen functional lncRNAs, which are believed to greatly drive the field and ultimately unravel the functionality enigma of organismal lncRNAs.

Author Contributions

Y.L., H.Z., L.T. and K.Z. contributed jointly to review, discussion, and writing. C.W. and Z.X. contributed partly to discussion. All authors have read and agreed to the published version of the manuscript.

Funding

National Natural Science Foundation of China (32170858, 82001613); Postdoctoral research foundation of China (2020M671540).

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Uszczynska-Ratajczak, B.; Lagarde, J.; Frankish, A.; Guigo, R.; Johnson, R. Towards a complete map of the human long non-coding RNA transcriptome. Nat. Rev. Genet. 2018, 19, 535–548. [Google Scholar] [CrossRef] [PubMed]
  2. Gao, F.; Cai, Y.; Kapranov, P.; Xu, D. Reverse-genetics studies of lncRNAs-what we have learnt and paths forward. Genome Biol. 2020, 21, 93. [Google Scholar] [CrossRef] [Green Version]
  3. Ma, L.; Cao, J.; Liu, L.; Du, Q.; Li, Z.; Zou, D.; Bajic, V.B.; Zhang, Z. LncBook: A curated knowledgebase of human long non-coding RNAs. Nucleic Acids Res. 2019, 47, 2699. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  4. Fatica, A.; Bozzoni, I. Long non-coding RNAs: New players in cell differentiation and development. Nat. Rev. Genet. 2014, 15, 7–21. [Google Scholar] [CrossRef] [PubMed]
  5. Rinn, J.L.; Chang, H.Y. Long Noncoding RNAs: Molecular Modalities to Organismal Functions. Annu. Rev. Biochem. 2020, 89, 283–308. [Google Scholar] [CrossRef] [PubMed]
  6. Joshi, M.; Rajender, S. Long non-coding RNAs (lncRNAs) in spermatogenesis and male infertility. Reprod. Biol. Endocrinol. RBE 2020, 18, 103. [Google Scholar] [CrossRef]
  7. Necsulea, A.; Soumillon, M.; Warnefors, M.; Liechti, A.; Daish, T.; Zeller, U.; Baker, J.C.; Grutzner, F.; Kaessmann, H. The evolution of lncRNA repertoires and expression patterns in tetrapods. Nature 2014, 505, 635–640. [Google Scholar] [CrossRef]
  8. Sarropoulos, I.; Marin, R.; Cardoso-Moreira, M.; Kaessmann, H. Developmental dynamics of lncRNAs across mammalian organs and species. Nature 2019, 571, 510–514. [Google Scholar] [CrossRef]
  9. Jandura, A.; Krause, H.M. The New RNA World: Growing Evidence for Long Noncoding RNA Functionality. Trends Genet. TIG 2017, 33, 665–676. [Google Scholar] [CrossRef]
  10. Brosius, J. Waste not, want not-transcript excess in multicellular eukaryotes. Trends Genet. TIG 2005, 21, 287–288. [Google Scholar] [CrossRef]
  11. Semon, M.; Duret, L. Evidence that functional transcription units cover at least half of the human genome. Trends Genet. TIG 2004, 20, 229–232. [Google Scholar] [CrossRef]
  12. Palazzo, A.F.; Lee, E.S. Non-coding RNA: What is functional and what is junk? Front. Genet. 2015, 6, 2. [Google Scholar] [CrossRef] [Green Version]
  13. Doolittle, W.F. We simply cannot go on being so vague about ‘function’. Genome Biol. 2018, 19, 223. [Google Scholar] [CrossRef]
  14. Kowalczyk, M.S.; Higgs, D.R.; Gingeras, T.R. Molecular biology: RNA discrimination. Nature 2012, 482, 310–311. [Google Scholar] [CrossRef]
  15. Struhl, K. Transcriptional noise and the fidelity of initiation by RNA polymerase II. Nat. Struct. Mol. Biol. 2007, 14, 103–105. [Google Scholar] [CrossRef] [PubMed]
  16. Palazzo, A.F.; Gregory, T.R. The case for junk DNA. PLoS Genet. 2014, 10, e1004351. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  17. Hangauer, M.J.; Vaughn, I.W.; McManus, M.T. Pervasive transcription of the human genome produces thousands of previously unidentified long intergenic noncoding RNAs. PLoS Genet. 2013, 9, e1003569. [Google Scholar] [CrossRef] [PubMed]
  18. Nobrega, M.A.; Zhu, Y.; Plajzer-Frick, I.; Afzal, V.; Rubin, E.M. Megabase deletions of gene deserts result in viable mice. Nature 2004, 431, 988–993. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  19. Han, X.; Luo, S.; Peng, G.; Lu, J.Y.; Cui, G.; Liu, L.; Yan, P.; Yin, Y.; Liu, W.; Wang, R.; et al. Mouse knockout models reveal largely dispensable but context-dependent functions of lncRNAs during development. J. Mol. Cell Biol. 2018, 10, 175–178. [Google Scholar] [CrossRef] [Green Version]
  20. Goudarzi, M.; Berg, K.; Pieper, L.M.; Schier, A.F. Individual long non-coding RNAs have no overt functions in zebrafish embryogenesis, viability and fertility. eLife 2019, 8, e40815. [Google Scholar] [CrossRef]
  21. Eissmann, M.; Gutschner, T.; Hammerle, M.; Gunther, S.; Caudron-Herger, M.; Gross, M.; Schirmacher, P.; Rippe, K.; Braun, T.; Zornig, M.; et al. Loss of the abundant nuclear non-coding RNA MALAT1 is compatible with life and development. RNA Biol. 2012, 9, 1076–1087. [Google Scholar] [CrossRef] [Green Version]
  22. Andergassen, D.; Rinn, J.L. From genotype to phenotype: Genetics of mammalian long non-coding RNAs in vivo. Nat. Rev. Genet. 2022, 23, 229–243. [Google Scholar] [CrossRef]
  23. Palazzo, A.F.; Koonin, E.V. Functional Long Non-coding RNAs Evolve from Junk Transcripts. Cell 2020, 183, 1151–1161. [Google Scholar] [CrossRef] [PubMed]
  24. Frankish, A.; Diekhans, M.; Ferreira, A.M.; Johnson, R.; Jungreis, I.; Loveland, J.; Mudge, J.M.; Sisu, C.; Wright, J.; Armstrong, J.; et al. GENCODE reference annotation for the human and mouse genomes. Nucleic Acids Res. 2019, 47, D766–D773. [Google Scholar] [CrossRef] [Green Version]
  25. Iyer, M.K.; Niknafs, Y.S.; Malik, R.; Singhal, U.; Sahu, A.; Hosono, Y.; Barrette, T.R.; Prensner, J.R.; Evans, J.R.; Zhao, S.; et al. The landscape of long noncoding RNAs in the human transcriptome. Nat. Genet. 2015, 47, 199–208. [Google Scholar] [CrossRef]
  26. Zhao, Y.; Li, H.; Fang, S.; Kang, Y.; Wu, W.; Hao, Y.; Li, Z.; Bu, D.; Sun, N.; Zhang, M.Q.; et al. NONCODE 2016: An informative and valuable data source of long non-coding RNAs. Nucleic Acids Res. 2016, 44, D203–D208. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  27. Consortium, E.P. An integrated encyclopedia of DNA elements in the human genome. Nature 2012, 489, 57–74. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  28. Deveson, I.W.; Hardwick, S.A.; Mercer, T.R.; Mattick, J.S. The Dimensions, Dynamics, and Relevance of the Mammalian Noncoding Transcriptome. Trends Genet. TIG 2017, 33, 464–478. [Google Scholar] [CrossRef]
  29. Cabili, M.N.; Trapnell, C.; Goff, L.; Koziol, M.; Tazon-Vega, B.; Regev, A.; Rinn, J.L. Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses. Genes. Dev. 2011, 25, 1915–1927. [Google Scholar] [CrossRef] [Green Version]
  30. Pauli, A.; Valen, E.; Lin, M.F.; Garber, M.; Vastenhouw, N.L.; Levin, J.Z.; Fan, L.; Sandelin, A.; Rinn, J.L.; Regev, A.; et al. Systematic identification of long noncoding RNAs expressed during zebrafish embryogenesis. Genome Res. 2012, 22, 577–591. [Google Scholar] [CrossRef] [Green Version]
  31. Guttman, M.; Rinn, J.L. Modular regulatory principles of large non-coding RNAs. Nature 2012, 482, 339–346. [Google Scholar] [CrossRef] [Green Version]
  32. Guttman, M.; Amit, I.; Garber, M.; French, C.; Lin, M.F.; Feldser, D.; Huarte, M.; Zuk, O.; Carey, B.W.; Cassady, J.P.; et al. Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature 2009, 458, 223–227. [Google Scholar] [CrossRef]
  33. Quinn, J.J.; Chang, H.Y. Unique features of long non-coding RNA biogenesis and function. Nat. Rev. Genet. 2016, 17, 47–62. [Google Scholar] [CrossRef]
  34. Kopp, F.; Mendell, J.T. Functional Classification and Experimental Dissection of Long Noncoding RNAs. Cell 2018, 172, 393–407. [Google Scholar] [CrossRef] [Green Version]
  35. Engreitz, J.M.; Haines, J.E.; Perez, E.M.; Munson, G.; Chen, J.; Kane, M.; McDonel, P.E.; Guttman, M.; Lander, E.S. Local regulation of gene expression by lncRNA promoters, transcription and splicing. Nature 2016, 539, 452–455. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  36. Guttman, M.; Donaghey, J.; Carey, B.W.; Garber, M.; Grenier, J.K.; Munson, G.; Young, G.; Lucas, A.B.; Ach, R.; Bruhn, L.; et al. lincRNAs act in the circuitry controlling pluripotency and differentiation. Nature 2011, 477, 295–300. [Google Scholar] [CrossRef] [Green Version]
  37. Stojic, L.; Lun, A.T.L.; Mangei, J.; Mascalchi, P.; Quarantotti, V.; Barr, A.R.; Bakal, C.; Marioni, J.C.; Gergely, F.; Odom, D.T. Specificity of RNAi, LNA and CRISPRi as loss-of-function methods in transcriptional analysis. Nucleic Acids Res. 2018, 46, 5950–5966. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  38. Bester, A.C.; Lee, J.D.; Chavez, A.; Lee, Y.R.; Nachmani, D.; Vora, S.; Victor, J.; Sauvageau, M.; Monteleone, E.; Rinn, J.L.; et al. An Integrated Genome-wide CRISPRa Approach to Functionalize lncRNAs in Drug Resistance. Cell 2018, 173, 649–664.e620. [Google Scholar] [CrossRef] [PubMed]
  39. Liu, S.J.; Horlbeck, M.A.; Cho, S.W.; Birk, H.S.; Malatesta, M.; He, D.; Attenello, F.J.; Villalta, J.E.; Cho, M.Y.; Chen, Y.; et al. CRISPRi-based genome-scale identification of functional long noncoding RNA loci in human cells. Science 2017, 355, eaah7111. [Google Scholar] [CrossRef] [Green Version]
  40. Arun, G.; Aggarwal, D.; Spector, D.L. MALAT1 Long Non-Coding RNA: Functional Implications. Non-Coding RNA 2020, 6, 22. [Google Scholar] [CrossRef]
  41. Zhang, B.; Arun, G.; Mao, Y.S.; Lazar, Z.; Hung, G.; Bhattacharjee, G.; Xiao, X.; Booth, C.J.; Wu, J.; Zhang, C.; et al. The lncRNA Malat1 is dispensable for mouse development but its transcription plays a cis-regulatory role in the adult. Cell Rep. 2012, 2, 111–123. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  42. Luo, S.; Lu, J.Y.; Liu, L.; Yin, Y.; Chen, C.; Han, X.; Wu, B.; Xu, R.; Liu, W.; Yan, P.; et al. Divergent lncRNAs Regulate Gene Expression and Lineage Differentiation in Pluripotent Cells. Cell Stem Cell 2016, 18, 637–652. [Google Scholar] [CrossRef] [PubMed]
  43. Schor, I.E.; Bussotti, G.; Males, M.; Forneris, M.; Viales, R.R.; Enright, A.J.; Furlong, E.E.M. Non-coding RNA Expression, Function, and Variation during Drosophila Embryogenesis. Curr. Biol. CB 2018, 28, 3547–3561.e3549. [Google Scholar] [CrossRef] [PubMed]
  44. George, M.R.; Duan, Q.; Nagle, A.; Kathiriya, I.S.; Huang, Y.; Rao, K.; Haldar, S.M.; Bruneau, B.G. Minimal in vivo requirements for developmentally regulated cardiac long intergenic non-coding RNAs. Development 2019, 146, dev185314. [Google Scholar] [CrossRef]
  45. Sauvageau, M.; Goff, L.A.; Lodato, S.; Bonev, B.; Groff, A.F.; Gerhardinger, C.; Sanchez-Gomez, D.B.; Hacisuleyman, E.; Li, E.; Spence, M.; et al. Multiple knockout mouse models reveal lincRNAs are required for life and brain development. eLife 2013, 2, e01749. [Google Scholar] [CrossRef] [Green Version]
  46. Wei, S.; Chen, H.; Dzakah, E.E.; Yu, B.; Wang, X.; Fu, T.; Li, J.; Liu, L.; Fang, S.; Liu, W.; et al. Systematic evaluation of C. elegans lincRNAs with CRISPR knockout mutants. Genome Biol. 2019, 20, 7. [Google Scholar] [CrossRef] [Green Version]
  47. Akay, A.; Jordan, D.; Navarro, I.C.; Wrzesinski, T.; Ponting, C.P.; Miska, E.A.; Haerty, W. Identification of functional long non-coding RNAs in C. elegans. BMC Biol. 2019, 17, 14. [Google Scholar] [CrossRef] [Green Version]
  48. Kuscu, C.; Arslan, S.; Singh, R.; Thorpe, J.; Adli, M. Genome-wide analysis reveals characteristics of off-target sites bound by the Cas9 endonuclease. Nat. Biotechnol. 2014, 32, 677–683. [Google Scholar] [CrossRef]
  49. Paralkar, V.R.; Taborda, C.C.; Huang, P.; Yao, Y.; Kossenkov, A.V.; Prasad, R.; Luan, J.; Davies, J.O.; Hughes, J.R.; Hardison, R.C.; et al. Unlinking an lncRNA from Its Associated cis Element. Mol. Cell 2016, 62, 104–110. [Google Scholar] [CrossRef] [Green Version]
  50. Meller, V.H.; Rattner, B.P. The roX genes encode redundant male-specific lethal transcripts required for targeting of the MSL complex. EMBO J. 2002, 21, 1084–1091. [Google Scholar] [CrossRef] [Green Version]
  51. Guo, C.J.; Ma, X.K.; Xing, Y.H.; Zheng, C.C.; Xu, Y.F.; Shan, L.; Zhang, J.; Wang, S.; Wang, Y.; Carmichael, G.G.; et al. Distinct Processing of lncRNAs Contributes to Non-conserved Functions in Stem Cells. Cell 2020, 181, 621–636.e622. [Google Scholar] [CrossRef] [PubMed]
  52. Nakagawa, S.; Naganuma, T.; Shioi, G.; Hirose, T. Paraspeckles are subpopulation-specific nuclear bodies that are not essential in mice. J. Cell Biol. 2011, 193, 31–39. [Google Scholar] [CrossRef] [PubMed]
  53. Nakagawa, S.; Shimada, M.; Yanaka, K.; Mito, M.; Arai, T.; Takahashi, E.; Fujita, Y.; Fujimori, T.; Standaert, L.; Marine, J.C.; et al. The lncRNA Neat1 is required for corpus luteum formation and the establishment of pregnancy in a subpopulation of mice. Development 2014, 141, 4618–4627. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  54. Perry, R.B.; Hezroni, H.; Goldrich, M.J.; Ulitsky, I. Regulation of Neuroregeneration by Long Noncoding RNAs. Mol. Cell 2018, 72, 553–567.e555. [Google Scholar] [CrossRef] [Green Version]
  55. Ponnusamy, M.; Liu, F.; Zhang, Y.H.; Li, R.B.; Zhai, M.; Liu, F.; Zhou, L.Y.; Liu, C.Y.; Yan, K.W.; Dong, Y.H.; et al. Long Noncoding RNA CPR (Cardiomyocyte Proliferation Regulator) Regulates Cardiomyocyte Proliferation and Cardiac Repair. Circulation 2019, 139, 2668–2684. [Google Scholar] [CrossRef]
  56. Zhu, P.; Wu, J.; Wang, Y.; Zhu, X.; Lu, T.; Liu, B.; He, L.; Ye, B.; Wang, S.; Meng, S.; et al. LncGata6 maintains stemness of intestinal stem cells and promotes intestinal tumorigenesis. Nat. Cell Biol. 2018, 20, 1134–1144. [Google Scholar] [CrossRef]
  57. Wen, K.; Yang, L.; Xiong, T.; Di, C.; Ma, D.; Wu, M.; Xue, Z.; Zhang, X.; Long, L.; Zhang, W.; et al. Critical roles of long noncoding RNAs in Drosophila spermatogenesis. Genome Res. 2016, 26, 1233–1244. [Google Scholar] [CrossRef] [Green Version]
  58. Koonin, E.V. The meaning of biological information. Philos. Trans. Ser. A Math. Phys. Eng. Sci. 2016, 374, 20150065. [Google Scholar] [CrossRef] [Green Version]
  59. Briggs, J.A.; Wolvetang, E.J.; Mattick, J.S.; Rinn, J.L.; Barry, G. Mechanisms of Long Non-coding RNAs in Mammalian Nervous System Development, Plasticity, Disease, and Evolution. Neuron 2015, 88, 861–877. [Google Scholar] [CrossRef] [Green Version]
  60. Necsulea, A.; Kaessmann, H. Evolutionary dynamics of coding and non-coding transcriptomes. Nat. Rev. Genet. 2014, 15, 734–748. [Google Scholar] [CrossRef]
  61. Soumillon, M.; Necsulea, A.; Weier, M.; Brawand, D.; Zhang, X.; Gu, H.; Barthes, P.; Kokkinaki, M.; Nef, S.; Gnirke, A.; et al. Cellular source and mechanisms of high transcriptome complexity in the mammalian testis. Cell Rep. 2013, 3, 2179–2190. [Google Scholar] [CrossRef] [PubMed]
  62. Werner, A.; Piatek, M.J.; Mattick, J.S. Transpositional shuffling and quality control in male germ cells to enhance evolution of complex organisms. Ann. N. Y. Acad. Sci. 2015, 1341, 156–163. [Google Scholar] [CrossRef] [Green Version]
  63. Watanabe, T.; Cheng, E.C.; Zhong, M.; Lin, H. Retrotransposons and pseudogenes regulate mRNAs and lncRNAs via the piRNA pathway in the germline. Genome Res. 2015, 25, 368–380. [Google Scholar] [CrossRef]
  64. Zhang, C.; Gao, L.; Xu, E.Y. LncRNA, a new component of expanding RNA-protein regulatory network important for animal sperm development. Semin. Cell Dev. Biol. 2016, 59, 110–117. [Google Scholar] [CrossRef] [PubMed]
  65. Luk, A.C.; Chan, W.Y.; Rennert, O.M.; Lee, T.L. Long noncoding RNAs in spermatogenesis: Insights from recent high-throughput transcriptome studies. Reproduction 2014, 147, R131–R141. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  66. Tzur, Y.B. lncRNAs in fertility: Redefining the gene expression paradigm? Trends Genet. TIG 2022, 38, 1170–1179. [Google Scholar] [CrossRef]
  67. Anguera, M.C.; Ma, W.; Clift, D.; Namekawa, S.; Kelleher, R.J., III; Lee, J.T. Tsx produces a long noncoding RNA and has general functions in the germline, stem cells, and brain. PLoS Genet. 2011, 7, e1002248. [Google Scholar] [CrossRef] [Green Version]
  68. Hong, S.H.; Han, G.; Lee, S.J.; Cocquet, J.; Cho, C. Testicular germ cell-specific lncRNA, Teshl, is required for complete expression of Y chromosome genes and a normal offspring sex ratio. Sci. Adv. 2021, 7, eabg5177. [Google Scholar] [CrossRef]
  69. Lewandowski, J.P.; Dumbovic, G.; Watson, A.R.; Hwang, T.; Jacobs-Palmer, E.; Chang, N.; Much, C.; Turner, K.M.; Kirby, C.; Rubinstein, N.D.; et al. The Tug1 lncRNA locus is essential for male fertility. Genome Biol. 2020, 21, 237. [Google Scholar] [CrossRef]
  70. Mise, S.; Matsumoto, A.; Shimada, K.; Hosaka, T.; Takahashi, M.; Ichihara, K.; Shimizu, H.; Shiraishi, C.; Saito, D.; Suyama, M.; et al. Kastor and Polluks polypeptides encoded by a single gene locus cooperatively regulate VDAC and spermatogenesis. Nat. Commun. 2022, 13, 1071. [Google Scholar] [CrossRef]
  71. Li, K.; Xu, J.; Luo, Y.; Zou, D.; Han, R.; Zhong, S.; Zhao, Q.; Mang, X.; Li, M.; Si, Y.; et al. Panoramic transcriptome analysis and functional screening of long noncoding RNAs in mouse spermatogenesis. Genome Res. 2021, 31, 13–26. [Google Scholar] [CrossRef]
  72. Chen, Y.; Zheng, Y.; Gao, Y.; Lin, Z.; Yang, S.; Wang, T.; Wang, Q.; Xie, N.; Hua, R.; Liu, M.; et al. Single-cell RNA-seq uncovers dynamic processes and critical regulators in mouse spermatogenesis. Cell Res. 2018, 28, 879–896. [Google Scholar] [CrossRef] [Green Version]
  73. Wichman, L.; Somasundaram, S.; Breindel, C.; Valerio, D.M.; McCarrey, J.R.; Hodges, C.A.; Khalil, A.M. Dynamic expression of long noncoding RNAs reveals their potential roles in spermatogenesis and fertility. Biol. Reprod. 2017, 97, 313–323. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  74. Kataruka, S.; Akhade, V.S.; Kayyar, B.; Rao, M.R.S. Mrhl Long Noncoding RNA Mediates Meiotic Commitment of Mouse Spermatogonial Cells by Regulating Sox8 Expression. Mol. Cell Biol. 2017, 37, e00632-16. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  75. Zhang, L.; Lu, H.; Xin, D.; Cheng, H.; Zhou, R. A novel ncRNA gene from mouse chromosome 5 trans-splices with Dmrt1 on chromosome 19. Biochem. Biophys. Res. Commun. 2010, 400, 696–700. [Google Scholar] [CrossRef]
  76. Liang, M.; Wang, H.; He, C.; Zhang, K.; Hu, K. LncRNA-Gm2044 is transcriptionally activated by A-MYB and regulates Sycp1 expression as a miR-335-3p sponge in mouse spermatocyte-derived GC-2spd(ts) cells. Differ. Res. Biol. Divers. 2020, 114, 49–57. [Google Scholar] [CrossRef]
  77. Chen, H.M.; Neiman, A.M. A conserved regulatory role for antisense RNA in meiotic gene expression in yeast. Curr. Opin. Microbiol. 2011, 14, 655–659. [Google Scholar] [CrossRef] [Green Version]
  78. Andric, V.; Rougemaille, M. Long Non-Coding RNAs in the Control of Gametogenesis: Lessons from Fission Yeast. Non-Coding RNA 2021, 7, 34. [Google Scholar] [CrossRef] [PubMed]
  79. Bridges, M.C.; Daulagala, A.C.; Kourtidis, A. LNCcation: LncRNA localization and function. J. Cell Biol. 2021, 220, e202009045. [Google Scholar] [CrossRef] [PubMed]
  80. Carlevaro-Fita, J.; Johnson, R. Global Positioning System: Understanding Long Noncoding RNAs through Subcellular Localization. Mol. Cell 2019, 73, 869–883. [Google Scholar] [CrossRef] [Green Version]
  81. Tabara, H.; Mitani, S.; Mochizuki, M.; Kohara, Y.; Nagata, K. A small RNA system ensures accurate homologous pairing and unpaired silencing of meiotic chromosomes. EMBO J. 2023, 42, e105002. [Google Scholar] [CrossRef] [PubMed]
  82. Meikar, O.; Vagin, V.V.; Chalmel, F.; Sostar, K.; Lardenois, A.; Hammell, M.; Jin, Y.; Da Ros, M.; Wasik, K.A.; Toppari, J.; et al. An atlas of chromatoid body components. RNA 2014, 20, 483–495. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  83. Wilk, R.; Hu, J.; Blotsky, D.; Krause, H.M. Diverse and pervasive subcellular distributions for both coding and long noncoding RNAs. Genes. Dev. 2016, 30, 594–609. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  84. Yang, L.Z.; Wang, Y.; Li, S.Q.; Yao, R.W.; Luan, P.F.; Wu, H.; Carmichael, G.G.; Chen, L.L. Dynamic Imaging of RNA in Living Cells by CRISPR-Cas13 Systems. Mol. Cell 2019, 76, 981–997.e987. [Google Scholar] [CrossRef] [PubMed]
  85. Cabili, M.N.; Dunagin, M.C.; McClanahan, P.D.; Biaesch, A.; Padovan-Merhar, O.; Regev, A.; Rinn, J.L.; Raj, A. Localization and abundance analysis of human lncRNAs at single-cell and single-molecule resolution. Genome Biol. 2015, 16, 20. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  86. Khong, A.; Matheny, T.; Jain, S.; Mitchell, S.F.; Wheeler, J.R.; Parker, R. The Stress Granule Transcriptome Reveals Principles of mRNA Accumulation in Stress Granules. Mol. Cell 2017, 68, 808–820.e805. [Google Scholar] [CrossRef]
  87. Benhalevy, D.; Anastasakis, D.G.; Hafner, M. Proximity-CLIP provides a snapshot of protein-occupied RNA elements in subcellular compartments. Nat. Methods 2018, 15, 1074–1082. [Google Scholar] [CrossRef]
  88. Clark, M.B.; Johnston, R.L.; Inostroza-Ponta, M.; Fox, A.H.; Fortini, E.; Moscato, P.; Dinger, M.E.; Mattick, J.S. Genome-wide analysis of long noncoding RNA stability. Genome Res. 2012, 22, 885–898. [Google Scholar] [CrossRef] [Green Version]
  89. Cheetham, S.W.; Faulkner, G.J.; Dinger, M.E. Overcoming challenges and dogmas to understand the functions of pseudogenes. Nat. Rev. Genet. 2020, 21, 191–201. [Google Scholar] [CrossRef]
  90. Guil, S.; Soler, M.; Portela, A.; Carrere, J.; Fonalleras, E.; Gomez, A.; Villanueva, A.; Esteller, M. Intronic RNAs mediate EZH2 regulation of epigenetic targets. Nat. Struct. Mol. Biol. 2012, 19, 664–670. [Google Scholar] [CrossRef]
  91. Hnisz, D.; Abraham, B.J.; Lee, T.I.; Lau, A.; Saint-Andre, V.; Sigova, A.A.; Hoke, H.A.; Young, R.A. Super-enhancers in the control of cell identity and disease. Cell 2013, 155, 934–947. [Google Scholar] [CrossRef] [Green Version]
  92. Shlyueva, D.; Stampfel, G.; Stark, A. Transcriptional enhancers: From properties to genome-wide predictions. Nat. Rev. Genet. 2014, 15, 272–286. [Google Scholar] [CrossRef] [PubMed]
  93. Mattick, J.S. Enhancers are genes that express organizational RNAs. Front. RNA Res. 2023, 1, 1194526. [Google Scholar] [CrossRef]
  94. Mattick, J.S.; Amaral, P.P.; Carninci, P.; Carpenter, S.; Chang, H.Y.; Chen, L.L.; Chen, R.; Dean, C.; Dinger, M.E.; Fitzgerald, K.A.; et al. Long non-coding RNAs: Definitions, functions, challenges and recommendations. Nat. Rev. Mol. Cell Biol. 2023, 24, 430–447. [Google Scholar] [CrossRef]
  95. Arner, E.; Daub, C.O.; Vitting-Seerup, K.; Andersson, R.; Lilje, B.; Drablos, F.; Lennartsson, A.; Ronnerblad, M.; Hrydziuszko, O.; Vitezic, M.; et al. Transcribed enhancers lead waves of coordinated transcription in transitioning mammalian cells. Science 2015, 347, 1010–1014. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  96. Hon, C.C.; Ramilowski, J.A.; Harshbarger, J.; Bertin, N.; Rackham, O.J.; Gough, J.; Denisenko, E.; Schmeier, S.; Poulsen, T.M.; Severin, J.; et al. An atlas of human long non-coding RNAs with accurate 5′ ends. Nature 2017, 543, 199–204. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  97. Harrison, L.J.; Bose, D. Enhancer RNAs step forward: New insights into enhancer function. Development 2022, 149, dev200398. [Google Scholar] [CrossRef]
  98. Cajigas, I.; Chakraborty, A.; Swyter, K.R.; Luo, H.; Bastidas, M.; Nigro, M.; Morris, E.R.; Chen, S.; VanGompel, M.J.W.; Leib, D.; et al. The Evf2 Ultraconserved Enhancer lncRNA Functionally and Spatially Organizes Megabase Distant Genes in the Developing Forebrain. Mol. Cell 2018, 71, 956–972.e959. [Google Scholar] [CrossRef] [Green Version]
  99. Groff, A.F.; Barutcu, A.R.; Lewandowski, J.P.; Rinn, J.L. Enhancers in the Peril lincRNA locus regulate distant but not local genes. Genome Biol. 2018, 19, 219. [Google Scholar] [CrossRef] [Green Version]
  100. Lewandowski, J.P.; Lee, J.C.; Hwang, T.; Sunwoo, H.; Goldstein, J.M.; Groff, A.F.; Chang, N.P.; Mallard, W.; Williams, A.; Henao-Meija, J.; et al. The Firre locus produces a trans-acting RNA molecule that functions in hematopoiesis. Nat. Commun. 2019, 10, 5137. [Google Scholar] [CrossRef] [Green Version]
  101. Allou, L.; Balzano, S.; Magg, A.; Quinodoz, M.; Royer-Bertrand, B.; Schopflin, R.; Chan, W.L.; Speck-Martins, C.E.; Carvalho, D.R.; Farage, L.; et al. Non-coding deletions identify Maenli lncRNA as a limb-specific En1 regulator. Nature 2021, 592, 93–98. [Google Scholar] [CrossRef] [PubMed]
  102. Brawand, D.; Soumillon, M.; Necsulea, A.; Julien, P.; Csardi, G.; Harrigan, P.; Weier, M.; Liechti, A.; Aximu-Petri, A.; Kircher, M.; et al. The evolution of gene expression levels in mammalian organs. Nature 2011, 478, 343–348. [Google Scholar] [CrossRef]
  103. Sassone-Corsi, P. Unique chromatin remodeling and transcriptional regulation in spermatogenesis. Science 2002, 296, 2176–2178. [Google Scholar] [CrossRef]
  104. Maezawa, S.; Sakashita, A.; Yukawa, M.; Chen, X.; Takahashi, K.; Alavattam, K.G.; Nakata, I.; Weirauch, M.T.; Barski, A.; Namekawa, S.H. Super-enhancer switching drives a burst in gene expression at the mitosis-to-meiosis transition. Nat. Struct. Mol. Biol. 2020, 27, 978–988. [Google Scholar] [CrossRef]
  105. Bassett, A.R.; Akhtar, A.; Barlow, D.P.; Bird, A.P.; Brockdorff, N.; Duboule, D.; Ephrussi, A.; Ferguson-Smith, A.C.; Gingeras, T.R.; Haerty, W.; et al. Considerations when investigating lncRNA function in vivo. eLife 2014, 3, e03058. [Google Scholar] [CrossRef]
  106. Liu, S.J.; Lim, D.A. Modulating the expression of long non-coding RNAs for functional studies. EMBO Rep. 2018, 19, e46955. [Google Scholar] [CrossRef] [PubMed]
  107. Rinaldi, C.; Wood, M.J.A. Antisense oligonucleotides: The next frontier for treatment of neurological disorders. Nat. Rev. Neurol. 2018, 14, 9–21. [Google Scholar] [CrossRef] [PubMed]
  108. Goyal, A.; Myacheva, K.; Gross, M.; Klingenberg, M.; Duran Arque, B.; Diederichs, S. Challenges of CRISPR/Cas9 applications for long non-coding RNA genes. Nucleic Acids Res. 2017, 45, e12. [Google Scholar] [CrossRef] [Green Version]
  109. Zeng, Y.; Cullen, B.R. RNA interference in human cells is restricted to the cytoplasm. RNA 2002, 8, 855–860. [Google Scholar] [CrossRef] [Green Version]
  110. Lennox, K.A.; Behlke, M.A. Cellular localization of long non-coding RNAs affects silencing by RNAi more than by antisense oligonucleotides. Nucleic Acids Res. 2016, 44, 863–877. [Google Scholar] [CrossRef] [Green Version]
  111. Derrien, T.; Johnson, R.; Bussotti, G.; Tanzer, A.; Djebali, S.; Tilgner, H.; Guernec, G.; Martin, D.; Merkel, A.; Knowles, D.G.; et al. The GENCODE v7 catalog of human long noncoding RNAs: Analysis of their gene structure, evolution, and expression. Genome Res. 2012, 22, 1775–1789. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  112. Abudayyeh, O.O.; Gootenberg, J.S.; Essletzbichler, P.; Han, S.; Joung, J.; Belanto, J.J.; Verdine, V.; Cox, D.B.T.; Kellner, M.J.; Regev, A.; et al. RNA targeting with CRISPR-Cas13. Nature 2017, 550, 280–284. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  113. Shoji, M.; Chuma, S.; Yoshida, K.; Morita, T.; Nakatsuji, N. RNA interference during spermatogenesis in mice. Dev. Biol. 2005, 282, 524–534. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  114. Dai, J.; Voloshin, O.; Potapova, S.; Camerini-Otero, R.D. Meiotic Knockdown and Complementation Reveals Essential Role of RAD51 in Mouse Spermatogenesis. Cell Rep. 2017, 18, 1383–1394. [Google Scholar] [CrossRef] [Green Version]
  115. Rigo, F.; Chun, S.J.; Norris, D.A.; Hung, G.; Lee, S.; Matson, J.; Fey, R.A.; Gaus, H.; Hua, Y.; Grundy, J.S.; et al. Pharmacology of a central nervous system delivered 2′-O-methoxyethyl-modified survival of motor neuron splicing oligonucleotide in mice and nonhuman primates. J. Pharmacol. Exp. Ther. 2014, 350, 46–55. [Google Scholar] [CrossRef] [Green Version]
  116. Gupta, A.; Andresen, J.L.; Manan, R.S.; Langer, R. Nucleic acid delivery for therapeutic applications. Adv. Drug Deliv. Rev. 2021, 178, 113834. [Google Scholar] [CrossRef]
  117. Lee, J.S.; Mendell, J.T. Antisense-Mediated Transcript Knockdown Triggers Premature Transcription Termination. Mol. Cell 2020, 77, 1044–1054.e1043. [Google Scholar] [CrossRef]
  118. Chen, Z.; Ling, L.; Shi, X.; Li, W.; Zhai, H.; Kang, Z.; Zheng, B.; Zhu, J.; Ye, S.; Wang, H.; et al. Microinjection of antisense oligonucleotides into living mouse testis enables lncRNA function study. Cell Biosci. 2021, 11, 213. [Google Scholar] [CrossRef]
  119. Wild, E.J.; Tabrizi, S.J. Therapies targeting DNA and RNA in Huntington’s disease. Lancet Neurol. 2017, 16, 837–847. [Google Scholar] [CrossRef] [Green Version]
  120. Dowdy, S.F. Overcoming cellular barriers for RNA therapeutics. Nat. Biotechnol. 2017, 35, 222–229. [Google Scholar] [CrossRef]
  121. Lin, N.; Chang, K.Y.; Li, Z.; Gates, K.; Rana, Z.A.; Dang, J.; Zhang, D.; Han, T.; Yang, C.S.; Cunningham, T.J.; et al. An evolutionarily conserved long noncoding RNA TUNA controls pluripotency and neural lineage commitment. Mol. Cell 2014, 53, 1005–1019. [Google Scholar] [CrossRef] [Green Version]
  122. Unfried, J.P.; Ulitsky, I. Substoichiometric action of long noncoding RNAs. Nat. Cell Biol. 2022, 24, 608–615. [Google Scholar] [CrossRef] [PubMed]
  123. Quinn, J.J.; Zhang, Q.C.; Georgiev, P.; Ilik, I.A.; Akhtar, A.; Chang, H.Y. Rapid evolutionary turnover underlies conserved lncRNA-genome interactions. Genes. Dev. 2016, 30, 191–207. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  124. Simko, E.A.J.; Liu, H.; Zhang, T.; Velasquez, A.; Teli, S.; Haeusler, A.R.; Wang, J. G-quadruplexes offer a conserved structural motif for NONO recruitment to NEAT1 architectural lncRNA. Nucleic Acids Res. 2020, 48, 7421–7438. [Google Scholar] [CrossRef]
  125. Li, G.; Ma, L.; He, S.; Luo, R.; Wang, B.; Zhang, W.; Song, Y.; Liao, Z.; Ke, W.; Xiang, Q.; et al. WTAP-mediated m6A modification of lncRNA NORAD promotes intervertebral disc degeneration. Nat. Commun. 2022, 13, 1469. [Google Scholar] [CrossRef]
  126. McGuire, A.L.; Gabriel, S.; Tishkoff, S.A.; Wonkam, A.; Chakravarti, A.; Furlong, E.E.M.; Treutlein, B.; Meissner, A.; Chang, H.Y.; Lopez-Bigas, N.; et al. The road ahead in genetics and genomics. Nat. Rev. Genet. 2020, 21, 581–596. [Google Scholar] [CrossRef]
  127. Kirk, J.M.; Kim, S.O.; Inoue, K.; Smola, M.J.; Lee, D.M.; Schertzer, M.D.; Wooten, J.S.; Baker, A.R.; Sprague, D.; Collins, D.W.; et al. Functional classification of long non-coding RNAs by k-mer content. Nat. Genet. 2018, 50, 1474–1482. [Google Scholar] [CrossRef]
  128. Khalil, A.M.; Guttman, M.; Huarte, M.; Garber, M.; Raj, A.; Rivea Morales, D.; Thomas, K.; Presser, A.; Bernstein, B.E.; van Oudenaarden, A.; et al. Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression. Proc. Natl. Acad. Sci. USA 2009, 106, 11667–11672. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  129. Xu, D.; Sun, L. HOTAIR underlies the region-specific development of adipose tissue. Nat. Rev. Endocrinol. 2022, 18, 663–664. [Google Scholar] [CrossRef]
  130. Mercer, T.R.; Dinger, M.E.; Sunkin, S.M.; Mehler, M.F.; Mattick, J.S. Specific expression of long noncoding RNAs in the mouse brain. Proc. Natl. Acad. Sci. USA 2008, 105, 716–721. [Google Scholar] [CrossRef] [Green Version]
  131. Uroda, T.; Anastasakou, E.; Rossi, A.; Teulon, J.M.; Pellequer, J.L.; Annibale, P.; Pessey, O.; Inga, A.; Chillon, I.; Marcia, M. Conserved Pseudoknots in lncRNA MEG3 Are Essential for Stimulation of the p53 Pathway. Mol. Cell 2019, 75, 982–995.e989. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  132. Qian, X.; Zhao, J.; Yeung, P.Y.; Zhang, Q.C.; Kwok, C.K. Revealing lncRNA Structures and Interactions by Sequencing-Based Approaches. Trends Biochem. Sci. 2019, 44, 33–52. [Google Scholar] [CrossRef]
  133. Lubelsky, Y.; Ulitsky, I. Sequences enriched in Alu repeats drive nuclear localization of long RNAs in human cells. Nature 2018, 555, 107–111. [Google Scholar] [CrossRef] [PubMed]
  134. Guo, C.J.; Xu, G.; Chen, L.L. Mechanisms of Long Noncoding RNA Nuclear Retention. Trends Biochem. Sci. 2020, 45, 947–960. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Physiologically functional lncRNAs in mouse testis. The physiological role of a few lncRNAs in mouse spermatogenesis has been studied by creating knockout mouse models. Most lncRNA knockouts delete the entire genomic locus. Other knockouts delete the functional element in the lncRNA locus, such as the ORF region in the Gm9999 locus. So far, only four lncRNAs have been demonstrated as functional in mouse testis. Tsx is highly expressed in pachytene spermatocytes and Tesh1 is mainly expressed in elongated spermatids. Tug1, Gm9999, and Tesh1 knockouts exhibit teratospermia and impaired male fertility. Mechanistically, Tsx acts in cis and Tesh1 in trans. Tug1 could act in cis, in trans, or by an encoded protein. Gm9999 executes its function through its two encoded polypeptides.
Figure 1. Physiologically functional lncRNAs in mouse testis. The physiological role of a few lncRNAs in mouse spermatogenesis has been studied by creating knockout mouse models. Most lncRNA knockouts delete the entire genomic locus. Other knockouts delete the functional element in the lncRNA locus, such as the ORF region in the Gm9999 locus. So far, only four lncRNAs have been demonstrated as functional in mouse testis. Tsx is highly expressed in pachytene spermatocytes and Tesh1 is mainly expressed in elongated spermatids. Tug1, Gm9999, and Tesh1 knockouts exhibit teratospermia and impaired male fertility. Mechanistically, Tsx acts in cis and Tesh1 in trans. Tug1 could act in cis, in trans, or by an encoded protein. Gm9999 executes its function through its two encoded polypeptides.
Ncrna 09 00036 g001
Figure 2. Schematic of present and future strategies to screen functional lncRNAs at the organismal level. We used mammalian testis as a model to depict these strategies. The present strategies tend to select lncRNA candidates based on tissue-specific, cell-type-predominant, or developmental dynamic expression patterns, co-expression with critical regulators, sequence conservation across species, genomic locus proximity to functional genes, and epigenetic marks for transcriptional activity (Table 1). Future strategies call for more attention to the molecular roles of lncRNAs including their subcellular localization, functional sequence, and structure, and interaction with other regulators or functional elements.
Figure 2. Schematic of present and future strategies to screen functional lncRNAs at the organismal level. We used mammalian testis as a model to depict these strategies. The present strategies tend to select lncRNA candidates based on tissue-specific, cell-type-predominant, or developmental dynamic expression patterns, co-expression with critical regulators, sequence conservation across species, genomic locus proximity to functional genes, and epigenetic marks for transcriptional activity (Table 1). Future strategies call for more attention to the molecular roles of lncRNAs including their subcellular localization, functional sequence, and structure, and interaction with other regulators or functional elements.
Ncrna 09 00036 g002
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Li, Y.; Zhai, H.; Tong, L.; Wang, C.; Xie, Z.; Zheng, K. LncRNA Functional Screening in Organismal Development. Non-Coding RNA 2023, 9, 36. https://doi.org/10.3390/ncrna9040036

AMA Style

Li Y, Zhai H, Tong L, Wang C, Xie Z, Zheng K. LncRNA Functional Screening in Organismal Development. Non-Coding RNA. 2023; 9(4):36. https://doi.org/10.3390/ncrna9040036

Chicago/Turabian Style

Li, Yang, Huicong Zhai, Lingxiu Tong, Cuicui Wang, Zhiming Xie, and Ke Zheng. 2023. "LncRNA Functional Screening in Organismal Development" Non-Coding RNA 9, no. 4: 36. https://doi.org/10.3390/ncrna9040036

APA Style

Li, Y., Zhai, H., Tong, L., Wang, C., Xie, Z., & Zheng, K. (2023). LncRNA Functional Screening in Organismal Development. Non-Coding RNA, 9(4), 36. https://doi.org/10.3390/ncrna9040036

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop